Ye D - Search Results

1

Gut Microbiome Fermentation Determines the Efficacy of Exercise for Diabetes Prevention.

Liu Y, Wang Y, Ni Y, Cheung CKY, Lam KSL, Wang Y, Xia Z, Ye D, Guo J, Tse MA, Panagiotou G, Xu A. Liu Y, et al. Among authors: ye d. Cell Metab. 2020 Jan 7;31(1):77-91.e5. doi: 10.1016/j.cmet.2019.11.001. Epub 2019 Nov 27. Cell Metab. 2020. PMID: 31786155 Free article. Clinical Trial.

2

Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice.

Ye D, Li FY, Lam KS, Li H, Jia W, Wang Y, Man K, Lo CM, Li X, Xu A. Ye D, et al. Gut. 2012 Jul;61(7):1058-67. doi: 10.1136/gutjnl-2011-300269. Epub 2012 Jan 17. Gut. 2012. PMID: 22253482

3

Caspase-3 as a therapeutic target for heart failure.

Yang B, Ye D, Wang Y. Yang B, et al. Among authors: ye d. Expert Opin Ther Targets. 2013 Mar;17(3):255-63. doi: 10.1517/14728222.2013.745513. Epub 2013 Jan 8. Expert Opin Ther Targets. 2013. PMID: 23294432 Review.

4

Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1α-mediated antioxidant capacity in mice.

Ye D, Wang Y, Li H, Jia W, Man K, Lo CM, Wang Y, Lam KS, Xu A. Ye D, et al. Hepatology. 2014 Sep;60(3):977-89. doi: 10.1002/hep.27060. Epub 2014 Jul 25. Hepatology. 2014. PMID: 24590984

5

Increased neutrophil elastase and proteinase 3 and augmented NETosis are closely associated with β-cell autoimmunity in patients with type 1 diabetes.

Wang Y, Xiao Y, Zhong L, Ye D, Zhang J, Tu Y, Bornstein SR, Zhou Z, Lam KS, Xu A. Wang Y, et al. Among authors: ye d. Diabetes. 2014 Dec;63(12):4239-48. doi: 10.2337/db14-0480. Epub 2014 Aug 4. Diabetes. 2014. PMID: 25092677

6

Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice.

Lin Z, Pan X, Wu F, Ye D, Zhang Y, Wang Y, Jin L, Lian Q, Huang Y, Ding H, Triggle C, Wang K, Li X, Xu A. Lin Z, et al. Among authors: ye d. Circulation. 2015 May 26;131(21):1861-71. doi: 10.1161/CIRCULATIONAHA.115.015308. Epub 2015 Mar 20. Circulation. 2015. PMID: 25794851 Free PMC article.

7

Circulating Fibroblast Growth Factor 21 Is A Sensitive Biomarker for Severe Ischemia/reperfusion Injury in Patients with Liver Transplantation.

Ye D, Li H, Wang Y, Jia W, Zhou J, Fan J, Man K, Lo C, Wong C, Wang Y, Lam KS, Xu A. Ye D, et al. Sci Rep. 2016 Jan 25;6:19776. doi: 10.1038/srep19776. Sci Rep. 2016. PMID: 26806156 Free PMC article.

8

Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice.

Gong Q, Hu Z, Zhang F, Cui A, Chen X, Jiang H, Gao J, Chen X, Han Y, Liang Q, Ye D, Shi L, Chin YE, Wang Y, Xiao H, Guo F, Liu Y, Zang M, Xu A, Li Y. Gong Q, et al. Among authors: ye d. Hepatology. 2016 Aug;64(2):425-38. doi: 10.1002/hep.28523. Epub 2016 Apr 15. Hepatology. 2016. PMID: 26926384 Free PMC article.

9

Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2.

Ye D, Yang K, Zang S, Lin Z, Chau HT, Wang Y, Zhang J, Shi J, Xu A, Lin S, Wang Y. Ye D, et al. J Hepatol. 2016 Nov;65(5):988-997. doi: 10.1016/j.jhep.2016.05.041. Epub 2016 Jun 4. J Hepatol. 2016. PMID: 27266617

10

Adipose-specific inactivation of JNK alleviates atherosclerosis in apoE-deficient mice.

Kwok KHM, Cheng KKY, Hoo RLC, Ye D, Xu A, Lam KSL. Kwok KHM, et al. Among authors: ye d. Clin Sci (Lond). 2016 Nov 1;130(22):2087-2100. doi: 10.1042/CS20160465. Epub 2016 Aug 10. Clin Sci (Lond). 2016. PMID: 27512097

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,936 results

Search Page

Filters